Bristol-Myers Relieves Its Headache
81672
The pharmaceutical giant is selling its pain relievers and other consumer products.
60593
Drug maker Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. said Friday that the Food and Drug Administration approved their antipsychotic drug Abilify for the treatment of acute bipolar mania.
435276
The troubled pharmaceutical company begins to show signs of life.
55431
In the long run, happy patients make happy shareholders.
138698
Another schizophrenia drug from the company shows promise in a clinical trial.
433149
A new surgical procedure may help millions of patients who suffer from debilitating migrane headaches. Plastic surgeons injecting patients with botox were able to discover which muscles triggered the migrane
109891
The troubles surrounding a major class of painkillers may ultimately help cure what has long ailed the US Food and Drug Administration.
492501
The biopharmaceutical company removes some uncertainty by teaming up with Novartis.
386372
Bristol-Myers Squibb Co. said on Sunday its experimental drug for rheumatoid arthritis showed highly promising results in two late-stage clinical trials.
348531
That would be small consolation to pharma investors.
146780
A drug has been found to slow a common cause of vision loss - and even improve sight in some patients.
452492
A synthetic form of a sea-snail venom was approved yesterday by the Food and Drug Administration as a novel approach to treating severe, chronic pain.
653673
A new drug that can treat patients with multiple sclerosis has been approved by the Food and Drug Administration but the high cost of the medication has some people concerned.
560604
The product is one of the biggest-selling medical devices in history. The side effect is rare and deadly. And the impact is a giant question mark hanging over Boston Scientific Corp. , the region's biggest life-science company.
582476
Charges to retire debt and finance the proposed settlement of a probe into its marketing practices more than offset strong sales growth at Bristol-Myers, which posted a loss of $133 million.
71368
Boston Scientific Corp. is putting its efforts to reach chronic pain sufferers on the fast track. The medical-device maker said it will sponsor a Formula race car team as part of a Race Against Pain marketing program.
220032
Bristol-Myers Squibb, the drug maker, has been cleared of securities law violations in connection with its botched Plavix patent settlement last year, the company said yesterday in a regulatory filing.